FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Stathopoulos

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Disorders

Concepts & Ideas

Activities & Behaviors

Patient Compliance

Co-author Network

Publications

TOP 3
George P Stathopoulos; John G Stathopoulos; Dimitrios T P Trafalis; IOANNIS DIMITROULIS; Ch Kosmas; Dimitrios Tsavdaridis
Combination of three cytotoxic agents in small-cell lung cancer.
Athanasios Armakolas; Adrianos Nezos; Martha Stathaki; George P Stathopoulos; Apostolos Theos; Michael Koutsilieris
Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients.
Helen Gogas; Haralabos P Kalofonos; Charisios Karanikiotis; Maria Karina; Paris Kosmidis; Christos Markopoulos; Christos Papadimitriou; Pavlos Papakostas; Dimitrios Pectasides; Epaminondas Samantas; George P Stathopoulos; Eleni Timotheadou; Dimitrios Bafaloukos; Anna Batistatou; Mattheos Bobos; Evangelos Briasoulis; Christos Christodoulou; Urania Dafni; Meletios A Dimopoulos; Anastasia G Eleftheraki; George Fountzilas
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Stathopoulos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: George P Stathopoulos; John G Stathopoulos; Dimitrios T P Trafalis; IOANNIS DIMITROULIS; Ch Kosmas; Dimitrios Tsavdaridis
Combination of three cytotoxic agents in small-cell lung cancer.
Cancer chemotherapy and pharmacology 2013;71(2):413-8.
2012: Athanasios Armakolas; Adrianos Nezos; Martha Stathaki; George P Stathopoulos; Apostolos Theos; Michael Koutsilieris
Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients.
Oncology reports 2012;28(6):2255-63.
2012: Helen Gogas; Haralabos P Kalofonos; Charisios Karanikiotis; Maria Karina; Paris Kosmidis; Christos Markopoulos; Christos Papadimitriou; Pavlos Papakostas; Dimitrios Pectasides; Epaminondas Samantas; George P Stathopoulos; Eleni Timotheadou; Dimitrios Bafaloukos; Anna Batistatou; Mattheos Bobos; Evangelos Briasoulis; Christos Christodoulou; Urania Dafni; Meletios A Dimopoulos; Anastasia G Eleftheraki; George Fountzilas
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Breast cancer research and treatment 2012;132(2):609-19.
2011: George P Stathopoulos; John G Stathopoulos; Dimosthenis Antoniou; IOANNIS DIMITROULIS; K Marosis; Pinelopi Michalopoulou
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 2011;68(4):945-50.
2011: George P Stathopoulos; Ch Zoublios; John G Stathopoulos
Metastatic lung disease treated with pemetrexed-docetaxel combination chemotherapy.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2011;16(1):166-9.
2010: George P Stathopoulos; D Antoniou; IOANNIS DIMITROULIS; P Michalopoulou; Antonios S. Bastas; K Marosis; John G Stathopoulos; A Provata; P Yiamboudakis; D Veldekis; N Lolis; N Georgatou; Michael Toubis; Ch Pappas; G Tsoukalas
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(11):2227-32.
2010: George P Stathopoulos
Liposomal cisplatin: a new cisplatin formulation.
Anti-cancer drugs 2010;21(8):732-6.
2010: George P Stathopoulos; Alexandros Ardavanis; Pavlos Papakotoulas; Dimitrios Pectasides; George Papadopoulos; Dimosthenis Antoniou; Athanasios Athanasiadis; Dimitrios Trafalis; Athanasios Anagnostopoulos; John Koutantos; Michael Vaslamatzis
Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I study.
Anti-cancer drugs 2010;21(2):202-5.
2010: George P Stathopoulos; C Batziou; D Trafalis; J Koutantos; S Batzios; John G Stathopoulos; J Legakis; A Armakolas
Treatment of colorectal cancer with and without bevacizumab: a phase III study.
Oncology 2010;78(5-6):376-81.
2009: George P Stathopoulos; G Papadopoulos; J Koutantos
Long-term survival of patients with carcinoid tumor and liver metastases.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2009;14(4):609-11.
2009: George P Stathopoulos; John Koutantos; Michael M Vaslamatzis; Athanasios Athanasiadis; George Papadopoulos; G Labrodimou; John G Stathopoulos; Sotiris K Rigatos
Survival after cytotoxic chemotherapy in patients with advanced hormone-resistant prostate cancer: a phase II study.
Oncology reports 2009;22(2):345-8.
2008: IOANNIS DIMITROULIS; Angeliki Rapti; George P Stathopoulos; Sotiris Rigatos; John Stathopoulos; John Koutantos; Athanasios Athanasiadis; Kyriaki Tsikritsaki; Dimitris Karaindros; Kostas Katis; Dimosthenis Antoniou; Michalis Toumbis; Pantelis Giamboudakis
Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III study.
Oncology reports 2008;20(4):879-84.
2008: Gerasimos Aravantinos; George Fountzilas; Aristotelis Bamias; Irene Grimani; Spyridon Rizos; Haralabos P Kalofonos; Dimosthenis V Skarlos; Theofanis Economopoulos; Paris A Kosmidis; George P Stathopoulos; Evangelos Briasoulis; Dimitrios Pectasides; Epaminondas Samantas; Eleni Timotheadou; Christos Papadimitriou; Alexandros Papanikolaou; Adimchi Onyenadum; Pavlos Papakostas; Dimitrios Bafaloukos; Meletios A Dimopoulos
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2169-77.
2008: George Fountzilas; Urania Dafni; Helen Gogas; Helena Linardou; Haralabos P Kalofonos; Evangelos Briasoulis; Dimitrios Pectasides; Epaminondas Samantas; Dimitrios Bafaloukos; George P Stathopoulos; Maria Karina; Christos Papadimitriou; Dimosthenis Skarlos; N Pisanidis; Pavlos Papakostas; Christos Markopoulos; E Tzorakoeleftherakis; K Dimitrakakis; P Makrantonakis; N Xiros; A Polichronis; I Varthalitis; Charisios Karanikiotis; Athanassios Meletios Dimopoulos
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):853-60.
2008: George P Stathopoulos; Nikos Androulakis; John Souglakos; John G Stathopoulos; Vassilis Georgoulias
Present treatment and future expectations in advanced pancreatic cancer.
Anticancer research 2008;28(2B):1303-8.
2008: George P Stathopoulos; John Koutantos; Sotiris K Rigatos; John G Stathopoulos; Spiros Batzios; Christina Batziou
Metastatic renal cancer and patient survival as a criterion of treatment response.
Oncology reports 2008;19(2):477-81.
2007: J Dahabre; M Vasilaki; George P Stathopoulos; A Kondaxis; Kosmas Iliadis; G Papadopoulos; John G Stathopoulos; Sotiris K Rigatos; K Vasilikos; J Koutantos
Surgical management in lung metastases from colorectal cancer.
Anticancer research 2007;27(6C):4387-90.
2007: George P Stathopoulos; IOANNIS DIMITROULIS; Michael Toubis; Costas Katis; Dimitris Karaindros; John G Stathopoulos; John Koutandos
Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: a phase I-II trial.
Lung cancer (Amsterdam, Netherlands) 2007;57(1):66-71.
2007: George P Stathopoulos; Nikolaos Malamos; Gerasimos Aravantinos; Sotiris K Rigatos; Ch Christodoulou; John G Stathopoulos; Dimosthenis Skarlos
Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancer.
Cancer chemotherapy and pharmacology 2007;60(1):123-8.
2007: George P Stathopoulos; J Koutantos; H Lazaki; Sotiris K Rigatos; John G Stathopoulos; George Deliconstantinos
Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.
Anticancer research 2007;27(3B):1653-6.
2007: Christos Kosmas; Nicolas Tsavaris; Konstantinos Syrigos; Angelos Koutras; George Tsakonas; Thomas Makatsoris; Nicolas Mylonakis; Athanasios Karabelis; George P Stathopoulos; Haralabos P Kalofonos
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
Cancer chemotherapy and pharmacology 2007;59(1):51-9.
2006: S Batzios; Argyris S Michalopoulos; L Kaklamanis; John G Stathopoulos; M Christopoulou; J Koutantos; George P Stathopoulos
Angiosarcoma of the heart: case report and review of the literature.
Anticancer research 2006;26(6C):4837-42.
2006: C Batziou; George P Stathopoulos; Kalliopi Petraki; Christos Papadimitriou; Sotiris K Rigatos; E Kondopodis; John G Stathopoulos; S Batzios
Primitive neurectodermal tumors: a case of extraosseous Ewing's sarcoma of the small intestine and review of the literature.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2006;11(4):519-22.
2006: George Fountzilas; Pavlos Papakostas; Urania Dafni; Thomas Makatsoris; Maria Karina; Anna Kalogera-Fountzila; N Maniadakis; Gerasimos Aravantinos; Konstantinos Syrigos; Aristotelis Bamias; Christos Christodoulou; Theofanis Economopoulos; Haralambos Kalofonos; Angelos Nikolaou; N Angouridakis; George P Stathopoulos; Dimitrios Bafaloukos; Nicholas Pavlidis; John Daniilidis
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1560-7.
2006: George P Stathopoulos; Costas Katis; Dimitrios Tsavdaridis; IOANNIS DIMITROULIS; Dimitris Karaindros; John G Stathopoulos; Evangelini Dimou
Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial.
Cancer chemotherapy and pharmacology 2006;58(4):555-60.
2006: George P Stathopoulos; Konstantinos Syrigos; Gerasimos Aravantinos; Aristidis Polyzos; Pavlos Papakotoulas; G Fountzilas; Anna Potamianou; Nikolaos Ziras; John Boukovinas; John Varthalitis; Nikolaos Androulakis; Athanasios Kotsakis; George Samonis; Vassilis Georgoulias
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
British journal of cancer 2006;95(5):587-92.
2006: Dimosthenis Antoniou; Georgia Pavlakou; George P Stathopoulos; Ioannis Karydis; Evangelia Chondrou; Chrysovalantis Papageorgiou; Fotini Dariotaki; Dimitra Chaimala; Marinos Veslemes
Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;53(2):205-10.
2006: George P Stathopoulos; Ch Christodoulou; John G Stathopoulos; Dimosthenis Skarlos; Sotiris K Rigatos; THEODORE GIANNAKAKIS; Ourania Armenaki; Dimosthenis Antoniou; Athanasios Athanasiadis; Pantelis Giamboudakis; IOANNIS DIMITROULIS; Niki Georgatou; Kostas Katis
Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study.
Cancer chemotherapy and pharmacology 2006;57(6):796-800.
2006: George P Stathopoulos; Teni Boulikas; Maria Vougiouka; Sotiris K Rigatos; John G Stathopoulos
Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: a phase I-II study.
Oncology reports 2006;15(5):1201-4.
2006: George P Stathopoulos; Teni Boulikas; Andreas Kourvetaris; John G Stathopoulos
Liposomal oxaliplatin in the treatment of advanced cancer: a phase I study.
Anticancer research 2006;26(2B):1489-93.
2006: IOANNIS DIMITROULIS; Michael Toubis; Dimosthenis Antoniou; C Marosis; U Armenaki; George P Stathopoulos; Pantelis Giamboudakis; Marinos Veslemes; Pinelopi Michalopoulou; F Christou; Niki Georgatou; T Grigoratou; Dimitris Karaindros; Kostas Katis
Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study.
Anticancer research 2006;26(2B):1397-402.
2006: Michail Ignatiadis; Aristidis Polyzos; George P Stathopoulos; Evangelos Tselepatiotis; Charalambos Christophylakis; Kostas Kalbakis; Lambros Vamvakas; Athanasios Kotsakis; Anna Potamianou; Vassilis Georgoulias
A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer.
Oncology 2006;71(3-4):159-63.
2005: George P Stathopoulos; Sotiris K Rigatos; John G Stathopoulos; John Xynotroulas; Evangelini Dimou
Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin.
American journal of clinical oncology 2005;28(6):565-9.
2005: Athanasios Athanasiadis; George Roussos; Thomas Papakostoulis; Daniela-Carmen Athanasiadou; George P Stathopoulos
Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase I study.
Cancer chemotherapy and pharmacology 2005;56(6):653-8.
2005: George P Stathopoulos; IOANNIS DIMITROULIS; Dimosthenis Antoniou; Costas Katis; Dimitrios Tsavdaridis; Ourania Armenaki; C Marosis; Pinelopi Michalopoulou; T Grigoratou; John G Stathopoulos
Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.
British journal of cancer 2005;93(10):1106-11.
2005: George P Stathopoulos; Dimitrios Tsavdaridis; Nikolaos Malamos; Sotiris K Rigatos; Christos Kosmas; N Pergantas; John G Stathopoulos; John Xynotroulas
Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study.
Cancer chemotherapy and pharmacology 2005;56(5):487-91.
2005: John G Stathopoulos; Dimosthenis Antoniou; George P Stathopoulos; Sotiris K Rigatos; IOANNIS DIMITROULIS; John Koutandos; Pinelopi Michalopoulou; Athanasios Athanasiades; Marinos Veslemes
Mesothelioma: treatment and survival of a patient population and review of the literature.
Anticancer research 2005;25(5):3671-6.
2005: Dimosthenis Antoniou; Konstantinos Kyprianou; George P Stathopoulos; Christos Skarleas; Georgia Kolitsi; Marinos Veslemes; IOANNIS DIMITROULIS; Pantelis Giamboudakis; Kostas Marosis; Ourania Armenaki; C Papageorgiou; Costas Katis
Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancer.
Oncology reports 2005;14(3):733-6.
2005: Teni Boulikas; George P Stathopoulos; Nikolaos Volakakis; Maria Vougiouka
Systemic Lipoplatin infusion results in preferential tumor uptake in human studies.
Anticancer research 2005;25(4):3031-9.
2005: Marinos Veslemes; Dimosthenis Antoniou; Niki Georgatou; Pantelis Giamboudakis; IOANNIS DIMITROULIS; Kostas Katis; George P Stathopoulos
Phase II study of cisplatin-combined schedules as second-line chemotherapy in patients with non-small cell lung cancer.
Anticancer research 2005;25(4):2991-6.
2005: Gerasimos Aravantinos; George Fountzilas; Paris A Kosmidis; Meletios A Dimopoulos; George P Stathopoulos; Nicholas Pavlidis; Dimitrios Bafaloukos; Christos Papadimitriou; S Karpathios; Vassilis Georgoulias; Pavlos Papakostas; Haralabos P Kalofonos; E Grimani; Dimosthenis V Skarlos
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
2005: George P Stathopoulos; Evangelini Dimou; John G Stathopoulos; John Xynotroulas
Therapeutic administration of pegfilgrastim instead of prophylactic use.
Anticancer research 2005;25(3c):2445-8.
2005: IOANNIS DIMITROULIS; George P Stathopoulos
Evolution of non-small cell lung cancer chemotherapy (Review).
Oncology reports 2005;13(5):923-30.
2005: George P Stathopoulos; Teni Boulikas; Maria Vougiouka; George Deliconstantinos; Sotiris K Rigatos; Eleftheria Darli; Vasiliki Viliotou; John G Stathopoulos
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study.
Oncology reports 2005;13(4):589-95.
2005: Nikolaos Androulakis; Konstantinos Syrigos; Aristidis Polyzos; Gerasimos Aravantinos; George P Stathopoulos; Nikolaos Ziras; Konstantinos Mallas; Lambros Vamvakas; Vassilis Georgoulis
Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study.
Cancer investigation 2005;23(1):9-12.
2004: George P Stathopoulos; Sotiris K Rigatos; Nikolaos Malamos; John G Stathopoulos; Panayiota Thallasinou; Ekaterini Papazachariou; Fotini Antoniou; Emmanuel Kondopodis; John Xynotroulas
Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapy.
Oncology reports 2004;12(6):1295-300.
2004: George P Stathopoulos; Sotiris K Rigatos; Christos Christodoulou; Nikolaos Malamos; Filippos Deliyiannis; John G Stathopoulos; Dimosthenis V Skarlos
Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study.
Cancer chemotherapy and pharmacology 2004;54(3):259-64.
2004: George P Stathopoulos; Marinos Veslemes; Niki Georgatou; Dimosthenis Antoniou; Pantelis Giamboudakis; Kostas Katis; Dimitrios Tsavdaridis; Sotiris K Rigatos; IOANNIS DIMITROULIS; S Bastani; Stelios Loukides; K Vergos; K Marossis; T Grigoratou; E Kalatzi; M Charalambatou; A Paspalli; Pinelopi Michalopoulou; M Stoka; Athina Gerogianni
Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(7):1048-55.
2004: Jim Janinis; George P Stathopoulos; Pavlos Nikolaidis; Haralabos P Kalofonos; Anna Kalogera-Fountzila; Epaminondas Samantas; Gerasimos Aravantinos; Athanassios Anagnostopoulos; Christos Tolis; Thomas Makatsoris; Sotiris K Rigatos; Dimitrios Bafaloukos; Meletios A Dimopoulos; John Daniilidis; George Fountzilas
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Anti-cancer drugs 2004;15(5):479-87.
2004: George P Stathopoulos; Konstantinos Syrigos; Aristidis Polyzos; G Fountzilas; Sotiris K Rigatos; Nikolaos Ziras; A Potamiannou; I Tsiakopoulos; Nikolaos Androulakis; Gerasimos Aravantinos; Athanasios Athanasiadis; Pavlos Papakotoulas; Vassilis Georgoulias
Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):224-9.
2004: George Fountzilas; George P Stathopoulos; George Kouvatseas; A Polychronis; George Klouvas; Epaminondas Samantas; Nikolaos Zamboglou; K Kyriakou; Adamos Adamou; D Pectasidis; Th Ekonomopoulos; Haralabos P Kalofonos; Dimitrios Bafaloukos; Vassilis Georgoulias; Evangelia Razis; Dimitrios Koukouras; V Zombolas; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
American journal of clinical oncology 2004;27(1):57-67.
2003: Sotiris K Rigatos; Dimitrios Tsavdaridis; Athanasios Athanasiadis; John G Stathopoulos; George P Stathopoulos
Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a phase II study.
Oncology reports 2003;10(6):1817-9.
2003: George P Stathopoulos; Marinos Veslemes; Niki Georgatou; Dimosthenis Antoniou; Dimitrios Tsavdaridis; Kostas Katis; Pantelis Giaboudakis; Sotiris K Rigatos; Kostas Marosis
Paclitaxel and vinorelbine combination in advanced inoperable adenocarcinoma of the lung: a phase II study.
Anticancer research 2003;23(4):3479-84.
2003: Athanasios Athanasiadis; Dimitrios Tsavdaridis; Sotiris K Rigatos; Ilias Athanasiadis; Nikolaos Pergantas; George P Stathopoulos
Hormone refractory advanced prostate cancer treated with estramustine and paclitaxel combination.
Anticancer research 2003;23(3C):3085-8.
2003: George P Stathopoulos; Sotiris K Rigatos; M A Dimopoulos; THEODORE GIANNAKAKIS; G Foutzilas; Charalambos Kouroussis; D Janninis; Gerasimos Aravantinos; Nikolaos Androulakis; Sofia Agelaki; John G Stathopoulos; Vassilis Georgoulias
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):388-94.
2002: George P Stathopoulos
Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review).
Oncology reports 2002;9(6):1257-9.
2002: George Koutinos; George P Stathopoulos; Ismene Dontas; Despina Perrea-Kotsarelis; Ephrosini Couris; Panayotis E Karayannacos; George Deliconstantinos
The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.
Anticancer research 2002;22(2A):815-20.
2002: Dimitrios Bafaloukos; Gerasimos Aravantinos; George Fountzilas; George P Stathopoulos; Helen Gogas; G Samonis; Evangelos Briasoulis; Nicolas Mylonakis; Dimosthenis V Skarlos; Paris A Kosmidis
Docetaxel in combination with dacarbazine in patients with advanced melanoma.
Oncology 2002;63(4):333-7.
2002: Sotiris K Rigatos; George P Stathopoulos; Ismene Dontas; Despina Perrea-Kotsarelis; Ephrosini Couris; Panayotis E Karayannacos; George Deliconstantinos
Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study.
Anticancer research 2002;22(1A):129-34.
2002: George P Stathopoulos; Sotiris K Rigatos; Nikos Pergantas; Dimitris Tsavdarides; Ilias Athanasiadis; Nikolaos Malamos; John G Stathopoulos
Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):37-41.
2002: George P Stathopoulos; Sotiris K Rigatos; G Fountzilas; Aristidis Polyzos; John G Stathopoulos
Paclitaxel and carboplatin in pretreated advanced gastric cancer: a phase II study.
Oncology reports 2002;9(1):89-92.
2001: George Samonis; Elpis Mantadakis; Theodore Kononas; Sotiris K Rigatos; George P Stathopoulos
Merkel cell carcinoma: a case series of twelve patients and review of the literature.
Anticancer research 2001;21(6A):4173-7.
2001: George Fountzilas; Dimitrios Tsavdaridis; Anna Kalogera-Fountzila; C H Christodoulou; Eleni Timotheadou; C H Kalofonos; Paris A Kosmidis; Adamos Adamou; Pavlos Papakostas; Helen Gogas; George P Stathopoulos; Evangelia Razis; Dimitrios Bafaloukos; Dimosthenis Skarlos
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1545-51.
2001: Manousos M Konstadoulakis; Pantelis T Antonakis; B G Tsibloulis; George P Stathopoulos; A P Manouras; DB Mylonaki; B X Golematis
A phase II study of 9-nitrocamptothecin in patients with advanced pancreatic adenocarcinoma.
Cancer chemotherapy and pharmacology 2001;48(5):417-20.
2001: George Fountzilas; Christos Papadimitriou; Gerasimos Aravantinos; Costas Nicolaides; George P Stathopoulos; Dimitrios Bafaloukos; Haralambos Kalofonos; T Ekonomopoulos; Dimosthenis Skarlos; Nicholas Pavlidis; Athanassios Meletios Dimopoulos
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer.
Oncology 2001;60(3):214-20.
2001: Nikiforos Kapranos; George P Stathopoulos; Leonidas Manolopoulos; E Kokka; Christos Papadimitriou; Athanasios Bibas; John Yiotakis; George Adamopoulos
p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
Anticancer research 2001;21(1B):521-8.
2001: George P Stathopoulos; Dimitris Mavroudis; Nicolas Tsavaris; Charalambos Kouroussis; Gerasimos Aravantinos; Sofia Agelaki; Stylianos Kakolyris; Sotiris K Rigatos; Spyros Karabekios; Vassilis Georgoulias
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):101-3.
2000: George P Stathopoulos; S P Dourakis; G Perdicaris; I E Promponas
Pleural effusion and pulmonary injury as an unusual complication to chemotherapy in non-small cell lung cancer patients.
Oncology reports 2000;7(6):1311-5.
2000: George P Stathopoulos; Nikiforos Kapranos; Leonidas Manolopoulos; Christos Papadimitriou; George Adamopoulos
Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
Anticancer research 2000;20(1A):177-82.
1999: Alexandra Giatromanolaki; George P Stathopoulos; E Tsiompanou; E Tsiobanou; C Papadimitriou; Vassilis Georgoulias; K C Gatter; A L Harris; Michael I Koukourakis
Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Cancer 1999;86(8):1421-30.
1999: George P Stathopoulos; Urania Dafni; Nikolaos Malamos; Sotiris K Rigatos; George Kouvatseas; N Moschopoulos
Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
Anticancer research 1999;19(4C):3543-8.
1999: George P Stathopoulos; Sotiris K Rigatos; Nikolaos Malamos
Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin.
Oncology reports 1999;6(4):797-800.
1999: Nikolaos Androulakis; Charalabos Kourousis; Meletios A Dimopoulos; Georgios Fotios Samelis; Stylianos Kakolyris; Nicolas Tsavaris; K Genatas; Gerasimos Aravantinos; Christos Papadimitriou; Spyros Karabekios; George P Stathopoulos; Vassilis Georgoulias
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1779-85.
1999: George Fountzilas; George P Stathopoulos; Costas Nicolaides; Anna Kalogera-Fountzila; Haralambos Kalofonos; Angelos Nikolaou; Christos Bacoyiannis; Epaminondas Samantas; Christos Papadimitriou; Paris A Kosmidis; John Daniilidis; Nicholas Pavlidis
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):475-8.
1998: George P Stathopoulos; Nikolaos Malamos; Ismene Dontas; George Deliconstantinos; D Perrea-Kotsareli; Panayotis E Karayannacos
Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: a potential free oxygen radical scavenger.
Anticancer research 1998;18(6A):4387-92.
1998: George Fountzilas; Costas Nicolaides; Gerasimos Aravantinos; Dimosthenis Skarlos; Paris A Kosmidis; Pavlos Papakostas; George P Stathopoulos; E Kontostolis; Dimitrios Bafaloukos; Nicholas Pavlidis
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.
Oncology 1998;55(6):508-12.
1998: Georgios Fotios Samelis; George P Stathopoulos; D Kotsarelis; Ismene Dontas; C Frangia; Panayotis E Karayannacos
Doxorubicin cardiotoxicity and serum lipid increase is prevented by dextrazoxane (ICRF-187).
Anticancer research 1998;18(5A):3305-9.
1997: Dimosthenis V Skarlos; Gerasimos Aravantinos; Paris A Kosmidis; AP Athanassiadis; George P Stathopoulos; Nicholas Pavlidis; Dimitrios Bafaloukos; S Karphathios; Pavlos Papakostas; Christina Bamia; George Fountzilas
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Seminars in oncology 1997;24(5 Suppl 15):S15-57-S15-61.
1997: George Fountzilas; Dimosthenis Skarlos; A Athanassiades; Anna Kalogera-Fountzila; Epaminondas Samantas; Christos Bacoyiannis; Angelos Nicolaou; Nicholas V Dombros; Evangelos Briasoulis; M Dinopoulou; George P Stathopoulos; Nicholas Pavlidis; Paris A Kosmidis; John Daniilidis
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):451-5.
1997: George Fountzilas; AP Athanassiadis; Epaminondas Samantas; Dimosthenis Skarlos; Anna Kalogera-Fountzila; Angelos Nikolaou; H Bacoyiannis; George P Stathopoulos; Paris A Kosmidis; John Daniilidis
Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.
Seminars in oncology 1997;24(1 Suppl 2):S2-65-S2-67.
1996: George P Stathopoulos; Constantin N Baxevanis; Nikolaos Papadopoulos; I K Zarkadis; P Papacostas; E Michailakis; M L Tsiatas; Michael Papamichail
Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Anticancer research 1996;16(6B):3855-60.
1996: George P Stathopoulos; Nikolaos Papadopoulos; A Stephanopoulou; Ismene Dontas; D Kotsarelis; Panayotis E Karayannacos
An increase of serum lipids after cumulative doses of doxorubicin and epirubicin in experimental animals.
Anticancer research 1996;16(6B):3429-33.
1996: Nikolaos Malamos; George P Stathopoulos; A Keramopoulos; J Papadiamantis; S Vassilaros
Pregnancy and offspring after the appearance of breast cancer.
Oncology 1996;53(6):471-5.
1995: Constantin N Baxevanis; G V Dedoussis; Nikolaos Papadopoulos; I Missitzis; C Beroukas; George P Stathopoulos; Michael Papamichail
Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.
Cancer 1995;76(7):1253-60.
1995: George P Stathopoulos; G S Stergiou; B Golematis; N Thalassinos; M Fillipakis
Effect of adriamycin, 5-fluorouracil and mitomycin-C combination chemotherapy in advanced colorectal cancer.
Oncology 1995;52(4):306-9.
1995: George P Stathopoulos; G S Stergiou; D N Perrea-Kostarelis; Ismene Dontas; B G Karamanos; P E Karayiannacos
Influence of 5-fluorouracil on serum lipids.
Acta oncologica (Stockholm, Sweden) 1995;34(2):253-6.
1994: Constantin N Baxevanis; G V Dedoussis; Angelos D Gritzapis; George P Stathopoulos; Michael Papamichail
Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.
British journal of cancer 1994;70(4):625-30.
1994: Constantin N Baxevanis; G V Dedoussis; Nikolaos Papadopoulos; I Missitzis; George P Stathopoulos; Michael Papamichail
Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Cancer 1994;74(4):1275-82.
1994: George P Stathopoulos; E Michailakis; Nikolaos Malamos
Vena caval obstruction by tumor.
The New England journal of medicine 1994;330(8):575.
1994: George P Stathopoulos; N Moschopoulos; E Apostolopoulou; Pavlos Papakostas; Georgios Fotios Samelis
Acute non-lymphocytic leukaemia complicating gastric cancer treated with epipodophyllotoxin containing chemotherapy and G-CSF.
Acta oncologica (Stockholm, Sweden) 1994;33(6):713-4.
1993: George Fountzilas; D Skarlos; D Theoharis; THEODORE GIANNAKAKIS; George P Stathopoulos
Carboplatin and oral etoposide in the treatment of patients with advanced breast cancer refractory to anthracyclines.
Tumori 1993;79(6):389-92.